We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
08 Apr 21
Trodelvy is an antibody and topoisomerase inhibitor conjugate that targets Trop-2 receptor, a protein often expressed in epithelial…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
01 Apr 21
With the acquisition, Piramal will benefit from Hemmo’s peptide API development and manufacturing capabilities
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
31 Mar 21
Rodeo’s preclinical programme targeting 15-PGDH will support Amgen in developing therapeutic agents against inflammatory disease indications
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
17 Mar 21
AbbVie has acquired the portfolio of women's drugs as part of its $63bn acquisition of Allergan, completed last…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
10 Mar 21
Takeda will obtain Maverick’s T-cell engager COBRA platform and its lead development candidates TAK-186 (MVC-101) and TAK-280 (MVC-280)
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
26 Feb 21
Takeda will continue to manufacture and supply the products under the sale to Teijin Pharma
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
02 Feb 21
Horizon will benefit from Viela Bio’s Uplizna, and additional investigational drug candidates VIB4920, VIB7734, and VIB1116
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
30 Dec 20
If the discussions are fruitful, Moderna is expected to supply 40 million doses of mRNA-1273 vaccine in South…
29 Dec 20
The generic glucagon is a synthetic version of human glucagon, a hormone that causes the liver to increase…
28 Dec 20
Covaxx, is currently conducting phase 1 clinical trial for the vaccine candidate
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates